PATENT CLAIM ANALYSIS

Application Number: 16043849
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "422000"]

Abstract:
The present invention provides a bionanocomposite including a pre-selected decellularized tissue crosslinked with a pre-selected nanomaterial. Also provided is a process for fabricating the bionanocomposite. Additionally, applications for using the bionanocomposite as soft tissue repair materials or scaffolds for tissue engineering are described.

Claim (Index 79):
A substantially planar membranous bionanocomposite of  claim 77  which is sufficiently resistant to shrinkage such that, after passage of at least 30, at least 60 or at least 90 days after surgical implantation, the area occupied by a projection of said substantially planar bionanocomposite on a plane generally parallel to a plane of best fit to the bionanocomposite remains at least 75%, at least 80%, at least 90% or at least 95% of the area occupied by a comparable projection of the composite prior to implantation.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 95.0
- Lexical Diversity: 1.38235
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15707178', '14193664', '15758511', '13155111', '15297535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7153362469743598
- 35 USC 102 Novelty (BERT): 0.5223641131696757
- Combined Prediction Score: 0.6960390335938914
- Mean Citation Score: 203.115244
- Max Citation Score: 213.96346
- Similarity Product: 100.786715028919

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test